# A Non-inferiority Study With Two Treatment Arms Eszopiclone 3 mg Versus Zopiclone 7.5 mg - for the Treatment of Insomnia

> **NCT01100164** · PHASE3 · COMPLETED · sponsor: **Eurofarma Laboratorios S.A.** · enrollment: 263 (actual)

## Conditions studied

- INSOMNIA

## Interventions

- **DRUG:** Eszopiclone
- **DRUG:** Zopiclone

## Key facts

- **NCT ID:** NCT01100164
- **Lead sponsor:** Eurofarma Laboratorios S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2012-03
- **Final completion:** 2012-04
- **Target enrollment:** 263 (ACTUAL)
- **Last updated:** 2015-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01100164

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01100164, "A Non-inferiority Study With Two Treatment Arms Eszopiclone 3 mg Versus Zopiclone 7.5 mg - for the Treatment of Insomnia". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01100164. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*